Healthcare provider profile · identity verified

David C Dobson, MD

Internal Medicine · BEVERLY, MA · NPI 1295833804

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	777	237
Levothyroxine Sodium	Levothyroxine Sodium	412	108
Omeprazole	Omeprazole	377	117
Losartan Potassium	Losartan Potassium	360	113
Amlodipine Besylate	Amlodipine Besylate	331	98
Metoprolol Succinate	Metoprolol Succinate	319	93
Gabapentin	Gabapentin	317	67
Metformin Hcl Er	Metformin Hcl	219	72
Atorvastatin Calcium	Atorvastatin Calcium	198	63
Eliquis	Apixaban	189	34
Lisinopril	Lisinopril	159	45
Oxycodone Hcl	Oxycodone Hcl	159	27
Famotidine	Famotidine	149	46
Albuterol Sulfate Hfa	Albuterol Sulfate	141	54
Simvastatin	Simvastatin	135	43
Tamsulosin Hcl	Tamsulosin Hcl	134	45
Trazodone Hcl	Trazodone Hcl	133	43
Pravastatin Sodium	Pravastatin Sodium	131	37
Tramadol Hcl	Tramadol Hcl	130	39
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	129	22
Irbesartan	Irbesartan	126	40
Furosemide	Furosemide	120	33
Fluticasone Propionate	Fluticasone Propionate	116	42
Clonazepam	Clonazepam	109	18
Hydrochlorothiazide	Hydrochlorothiazide	103	33
Xarelto	Rivaroxaban	98	21
Duloxetine Hcl	Duloxetine Hcl	96	30
Sertraline Hcl	Sertraline Hcl	93	29
Fluoxetine Hcl	Fluoxetine Hcl	91	28
Nebivolol Hcl	Nebivolol Hcl	84	29
Pantoprazole Sodium	Pantoprazole Sodium	81	26
Jardiance	Empagliflozin	79	17
Cephalexin	Cephalexin	75	52
Valsartan	Valsartan	73	31
Bupropion Hcl Sr	Bupropion Hcl	71	20
Metformin Hcl	Metformin Hcl	71	20
Wixela Inhub	Fluticasone Propion/Salmeterol	67	20
Finasteride	Finasteride	66	20
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	66	14
Celecoxib	Celecoxib	65	14
Nystatin	Nystatin	65	30
Atenolol	Atenolol	64	19
Pregabalin	Pregabalin	62	11
Zolpidem Tartrate	Zolpidem Tartrate	62	13
Mirtazapine	Mirtazapine	61	21
Donepezil Hcl	Donepezil Hcl	59	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	58	38
Allopurinol	Allopurinol	57	19
Alprazolam	Alprazolam	57	15
Montelukast Sodium	Montelukast Sodium	57	22
Venlafaxine Hcl Er	Venlafaxine Hcl	56	16
Clopidogrel	Clopidogrel Bisulfate	55	14
Lorazepam	Lorazepam	55	19
Spironolactone	Spironolactone	55	18
Colchicine	Colchicine	53	22
Felodipine Er	Felodipine	53	19
Hydralazine Hcl	Hydralazine Hcl	50	12
Valacyclovir	Valacyclovir Hcl	49	21
Bisoprolol Fumarate	Bisoprolol Fumarate	44	15
Warfarin Sodium	Warfarin Sodium	44	19
Rybelsus	Semaglutide	43	suppressed
Acyclovir	Acyclovir	42	21
Amoxicillin	Amoxicillin	42	30
Mupirocin	Mupirocin	42	24
Sumatriptan Succinate	Sumatriptan Succinate	41	suppressed
Ozempic	Semaglutide	40	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	40	20
Meloxicam	Meloxicam	39	15
Paroxetine Hcl	Paroxetine Hcl	39	suppressed
Memantine Hcl	Memantine Hcl	38	suppressed
Alendronate Sodium	Alendronate Sodium	37	12
Escitalopram Oxalate	Escitalopram Oxalate	37	16
Ibuprofen	Ibuprofen	37	suppressed
Torsemide	Torsemide	37	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	36	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	35	12
Prednisone	Prednisone	35	25
Carvedilol	Carvedilol	34	13
Baclofen	Baclofen	33	suppressed
Trulicity	Dulaglutide	33	suppressed
Diazepam	Diazepam	32	suppressed
Diclofenac Sodium	Diclofenac Sodium	32	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	32	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	30	suppressed
Azithromycin	Azithromycin	29	22
Ketoconazole	Ketoconazole	29	16
Buspirone Hcl	Buspirone Hcl	26	suppressed
Lidocaine	Lidocaine	26	suppressed
Ventolin Hfa	Albuterol Sulfate	26	suppressed
Chlorthalidone	Chlorthalidone	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	11
Incruse Ellipta	Umeclidinium Bromide	25	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Meclizine Hcl	Meclizine Hcl	25	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	24	suppressed
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Ondansetron Odt	Ondansetron	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Cefuroxime	Cefuroxime Axetil	23	18
Diltiazem 24hr Er	Diltiazem Hcl	23	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Lamotrigine	Lamotrigine	23	suppressed
Nitroglycerin Patch	Nitroglycerin	23	suppressed
Potassium Chloride	Potassium Chloride	23	11
Synthroid	Levothyroxine Sodium	23	suppressed
Testosterone	Testosterone	23	suppressed
Ipratropium Bromide	Ipratropium Bromide	22	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	22	suppressed
Nitroglycerin	Nitroglycerin	22	12
Fentanyl	Fentanyl	21	suppressed
Tradjenta	Linagliptin	20	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	19	12
Colestipol Hcl	Colestipol Hcl	19	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	19	suppressed
Diflunisal	Diflunisal	18	suppressed
Glimepiride	Glimepiride	18	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Methadone Hcl	Methadone Hcl	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Oxycontin	Oxycodone Hcl	18	suppressed
Vancomycin Hcl	Vancomycin Hcl	17	suppressed
Icosapent Ethyl	Icosapent Ethyl	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Divalproex Sodium	Divalproex Sodium	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Morphine Sulfate Er	Morphine Sulfate	15	suppressed
Naproxen	Naproxen	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Testosterone Cypionate	Testosterone Cypionate	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Zafirlukast	Zafirlukast	15	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	13	suppressed
Fondaparinux Sodium	Fondaparinux Sodium	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Primidone	Primidone	13	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Levocarnitine	Levocarnitine	12	suppressed
Trimethoprim	Trimethoprim	12	suppressed
Trulance	Plecanatide	12	suppressed
Wegovy	Semaglutide	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Copaxone	Glatiramer Acetate	11	suppressed
Eplerenone	Eplerenone	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Potassium Citrate Er	Potassium Citrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error